BioNTech SE (BNTX) Assets (2018 - 2024)
BioNTech SE's Assets history spans 4 years, with the latest figure at $18.1 billion for Q4 2021.
- For Q4 2021, Assets rose 555.1% year-over-year to $18.1 billion; the TTM value through Dec 2021 reached $18.1 billion, up 555.1%, while the annual FY2021 figure was $18.1 billion, 555.1% up from the prior year.
- Assets for Q4 2021 was $18.1 billion at BioNTech SE, up from $2.8 billion in the prior quarter.
- Across five years, Assets topped out at $18.1 billion in Q4 2021 and bottomed at $745.3 million in Q4 2018.
- The 4-year median for Assets is $1.8 billion (2020), against an average of $5.6 billion.
- The largest annual shift saw Assets rose 18.46% in 2019 before it soared 555.1% in 2021.
- A 4-year view of Assets shows it stood at $745.3 million in 2018, then rose by 18.46% to $882.9 million in 2019, then soared by 213.11% to $2.8 billion in 2020, then skyrocketed by 555.1% to $18.1 billion in 2021.
- Per Business Quant, the three most recent readings for BNTX's Assets are $18.1 billion (Q4 2021), $2.8 billion (Q4 2020), and $882.9 million (Q4 2019).